Your browser doesn't support javascript.
loading
Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 Inhibition.
Ishizawa, Jo; Nakamaru, Kenji; Seki, Takahiko; Tazaki, Koichi; Kojima, Kensuke; Chachad, Dhruv; Zhao, Ran; Heese, Lauren; Ma, Wencai; Ma, Man Chun John; DiNardo, Courtney; Pierce, Sherry; Patel, Keyur P; Tse, Archie; Davis, R Eric; Rao, Arvind; Andreeff, Michael.
Afiliação
  • Ishizawa J; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Nakamaru K; Daiichi Sankyo Co., Ltd., Hiromachi, Shinagawa-ku, Tokyo, Japan.
  • Seki T; Daiichi Sankyo Co., Ltd., Hiromachi, Shinagawa-ku, Tokyo, Japan.
  • Tazaki K; Daiichi Sankyo Co., Ltd., Hiromachi, Shinagawa-ku, Tokyo, Japan.
  • Kojima K; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Chachad D; Hematology, Respiratory Medicine and Oncology, Department of Medicine, Saga University, Saga, Japan.
  • Zhao R; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Heese L; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ma W; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ma MCJ; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • DiNardo C; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Pierce S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Patel KP; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Tse A; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Davis RE; Daiichi Sankyo, Inc., Edison, New Jersey.
  • Rao A; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Andreeff M; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Cancer Res ; 78(10): 2721-2731, 2018 05 15.
Article em En | MEDLINE | ID: mdl-29490944
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Proteína Supressora de Tumor p53 / Proteínas Proto-Oncogênicas c-mdm2 / Antineoplásicos Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Female / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Proteína Supressora de Tumor p53 / Proteínas Proto-Oncogênicas c-mdm2 / Antineoplásicos Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Female / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2018 Tipo de documento: Article